Postoperative aRCH With Cisplatin Versus aRCH With Cisplatin and Pembrolizumab in Locally Advanced Head and Neck Squamous Cell Carcinoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This trial evaluates the addition of pembrolizumab to standard postoperative adjuvant radiochemotherapy in the treatment of patients with locally advanced intermediate and high risk head and neck squamous cell carcinoma (HNSCC).
Epistemonikos ID: 5e6151093d6fafabcc5d3d24cb97a9591eaa4ccb
First added on: May 21, 2024